Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
Go back to Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio| (NASDAQ: CERT) | Delayed: 9.11 +0.22 (2.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.89 | 52 Week High | $ | |||
| Open | $8.96 | 52 Week Low | $ | |||
| Day High | $9.21 | P/E | N/A | |||
| Day Low | $8.74 | EPS | $ | |||
| Volume | 2,823,261 | |||||

